Short Description
This product is a Cypridina-luciferin 2-monooxygenase-targeted RNA modification and metabolomics analysis tool based on the ψ (METTL3-YTHDF1-FTO-KMTs-Cy7) modification and Glycogen synthesis-mediated (hnRNPs-Lactyl-CoA-NAD+) metabolic analysis system.
Oligonucleotide
Undisclosed, GalNac
RNA Construction
mRNAs-ψ-METTL3-YTHDF1-FTO-KMTs-Cy7
Pathway
Glycogen synthesis
Epigenetic regulator
ARID1A deficiency
Metabolic alteration
Upregulating glutamine metabolism
Targeting diseases
Adrenocortical carcinoma
RNA-binding proteins
hnRNPs
Metabolic Reprogramming
Glycogen synthesis-hnRNPs-Lactyl-CoA-NAD+